glp-1 receptor agonists in pediatric and adolescent obesity GLP1 Agonists—Effects beyond Diabetes Frontiers | Exploring the multifaceted
Description
The safety profile was similar to other incretin-based therapies
GLP-1RA use was significantly associated with a lower risk of all-cause mortality in this cohort compared to insulin/metformin use
Back Kolata, G (23 Sept 1997) 'How Fen-Phen, 'a diet miracle,' rose and fell, The New York Times
doi: 10.1001/jama.2023.19574 15 ZhengZZongYMaYTianYPangYZhangCet al
While Victoza is not a weight loss medication, a study found that adults lost an average of up to 6.2 pounds when Victoza was used with metformin, another prescription medication for type 2 diabetes
